Skip to content
CompanySight
Company No. 03354124 · Incorporated 11 Apr 1997

Milpharm Limited

Registered name: MILPHARM LIMITED

Part of Agile Pharma B.V. group

Milpharm Limited made £57.9m revenue and £2.5m profit in the year to 31 Mar 2026.

Milpharm Limited’s revenue fell 13% to £57.9m in the year to 31 Mar 2026, with £2.5m profit and 61 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Uxbridge; we hold 2 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods
Status
Active
Location
Uxbridge, London
Age
29 yrs · since 1997
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Mar 2026

Key figures

Capital-light
Revenue
£57.9m
Growth ▼12.5%
Profit
£2.5m
Growth ▼54.6%
Profit margin
4.3%
Gross 15.6%
Employees
61
Change ▼1.6%
Profit / employee
£40.4k
Revenue/employee £950k
Profitable streak
2yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Mar 202531 Mar 2026
DisclosureFull P&LFull P&L
Profit & loss
Revenue (turnover)£66.2m£57.9m
Cost of sales£55.2m£48.9m
Gross profit£11m£9m
Operating profit£5.6m£2.2m
Profit before tax£7.2m£3.3m
Profit after tax£5.4m£2.5m
Profit (best available)£5.4m£2.5m
Staff costs£5.3m£5.5m
Employees (average)6261
Ratios
Profit margin8.2%4.3%
Gross margin16.7%15.6%
Revenue per employee£1.1m£950k
Profit per employee£87.5k£40.4k
Growth (year on year)
Revenue growth—▼12.5%
Profit growth—▼54.6%
Headcount growth—▼1.6%
Balance sheet — indirect signals, not revenue
Cash at bank£72.7m£47.2m
Net assets£37.6m£39.3m
Fixed assets£1.8m£5.6m
Current assets£103m£81.3m
Debtors£14.8m£14.4m
SourceFullAccounts · bulk data Jun 2026FullAccounts · bulk data Jun 2026
Derived from the latest filing

How the business works

Profit margin
4.3%
Profit ÷ revenue.
Gross margin
15.6%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£950k
Revenue ÷ average employees.
Profit per employee
£40.4k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
9.6%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
24.9%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▲4%
Now £39.3m
Cash at bank
▼35%
Now £47.2m
Headcount
▼2%
Now 61
Deferred income
—
Now —
Fixed assets
▲204%
Now £5.6m
Corporate ownership

Group structure

Ownership chain

  1. Agile Pharma B.V. (registered outside the UK register)ultimate parent75–100%
  2. Milpharm Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Mar 2026 (profit £2.5m), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.